by admin | Mar 25, 2025 | News & Opinions
by Laura Kelley – University of Colorado Cancer Center – Researchers at CU Anschutz Medical Campus have developed ALA-CART, a next-generation therapy aimed at improving outcomes for patients with resistant cancers. “This next-generation approach, called...
by admin | Mar 24, 2025 | News & Opinions
by Morgridge Institute for Research – MedicalXpress – Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the University of Wisconsin–Madison have been at the forefront of stem cell research and...
by admin | Mar 21, 2025 | News & Opinions
By Frank Vinluan – MedCity News – Neurotech Pharmaceuticals’ surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). It’s the first therapy for this rare retinal degeneration disorder....
by admin | Mar 20, 2025 | News & Opinions
By Mass General Brigham – A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson’s disease in which a patient’s stem cells are reprogrammed to replace...
by admin | Mar 19, 2025 | News & Opinions
By Technology Networks – Reprogrammed stem cells to replace dopamine cells in the brain may offer hope for Parkinson’s treatment. A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking...
